Company / Net Income
10x Genomics, Inc. Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$43.5M
FY2025
5-year range
-$542.7M / -$31.3M
FY2021-FY2025
Trend
+76.2%
vs FY2024
Sector context
#114 of 164
Health Care
What the data says
At -$44M, 10x Genomics, Inc.'s net income ranks #114 of 164 in the Health Care sector. Net Income has increased for 3 consecutive years, from -$543M in FY2022 to -$44M in FY2025.
Based on SEC 10-K filings.
-$44M in FY2025.
Improved from -$255M to -$44M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 164 in Health CareTop 70% of 164This company -$43.5M Sector average $467.5M
▼
-109.3% below sector average
Key checks
Key Insights
- 10x Genomics, Inc.'s net income has grown for 3 consecutive years.
- In FY2025, net income increased 76.2% year-over-year.
- Ranks #114 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$43.5M | +76.2% |
| FY2024 | -$182.6M | +28.4% |
| FY2023 | -$255.1M | +53.0% |
| FY2022 | -$542.7M | -1636.7% |
| FY2021 | -$31.3M | +94.2% |
| FY2020 | -$542.7M | -1636.7% |
| FY2019 | -$31.3M | +72.2% |
| FY2018 | -$112.5M | -499.5% |
| FY2017 | -$18.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026